![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Elger, T.; Decker, T.; Fehm, T.; Fuxius, S.; Harbeck, N.; Juhasz-Böss, I.; Möbus, V.; Thomssen, C.; Seehase, M.; Schollenberger, L.; Ruckes, C. und Schmidt, M.
(2017):
VinoMetro: Phase II study of metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic hormone receptor positive (HR plus )/human epidermal growth factor receptor 2 negative (HER2-) breast cancer resistant to endocrine therapy.
In: Annals of Oncology, Bd. 28
Krajnak, S.; Decker, T.; Fehm, T.; Fuxius, S.; Harbeck, N.; Juhasz-Böss, I.; Möbus, V.; Thomssen, C.; Seehase, M.; Schollenberger, L.; Ruckes, C. und Schmidt, M.
(2017):
VinoMetro: phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy.
In: Oncology Research and Treatment, Bd. 40: S. 88